10-Q/A Filing

GLUCOSE HEALTH, INC. CIK: 1420108 Q2 2011

Filing Information

Form Type	10-Q/A
Accession Number	`0001096350-11-000145`
Period End Date	20110630
Filing Date	20110928
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	bisu-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 15 Income Statement 62 Cash Flow Statement 31

Balance Sheet 15 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$33.00	USD	Point-in-time
Inventory	`InventoryNet`	$87.76K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$87.79K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayable`	$384.51K	USD	Point-in-time
Short - term loans	`ShortTermBankLoansAndNotesPayable`	$243.77K	USD	Point-in-time
Short - term loans - related party	`ShortTermBorrowings`	$49.23K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholders`	$4.86K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$682.36K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$682.36K	USD	Point-in-time
Common stock	`CommonStockValue`	$19.73K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$1.60M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-2.14M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossBeforeTax`	$-68.02K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-614.30K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$68.06K	USD	Point-in-time

Income Statement 62 line items

Line Item	Tag	Value	Unit	Period
Beginning inventory	`BeginningInventory1`	$87.76K	USD	2 Qtrs
Beginning inventory	`BeginningInventory1`	$82.20K	USD	2 Qtrs
Beginning inventory	`BeginningInventory1`	$89.82K	USD	1 Quarter
Beginning inventory	`BeginningInventory1`	$89.37K	USD	1 Quarter
Purchases	`Purchases1`	$-3.79K	USD	1 Quarter
Purchases	`Purchases1`	$3.38K	USD	2 Qtrs
Ending inventory	`EndingInventory1`	$-90.52K	USD	2 Qtrs
Ending inventory	`EndingInventory1`	$-90.52K	USD	1 Quarter
Ending inventory	`EndingInventory1`	$-85.59K	USD	1 Quarter
Ending inventory	`EndingInventory1`	$-85.59K	USD	2 Qtrs
Total Cost of Revenues	`CostOfRevenue`	$-2.76K	USD	2 Qtrs
Total Cost of Revenues	`CostOfRevenue`	$-698.00	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	$698.00	USD	1 Quarter
GROSS PROFIT (LOSS)	`GrossProfit`	$2.76K	USD	2 Qtrs
Professional fees and wages	`ProfessionalFeesAndWages1`	$448.89K	USD	1 Quarter
Professional fees and wages	`ProfessionalFeesAndWages1`	$550.27K	USD	2 Qtrs
Professional fees and wages	`ProfessionalFeesAndWages1`	$133.84K	USD	1 Quarter
Professional fees and wages	`ProfessionalFeesAndWages1`	$372.30K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.82K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$49.63K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$21.50K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.76K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$453.65K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$421.93K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$155.35K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$560.10K	USD	2 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`NETLOSSBEFOREOTHEREXPENSE1`	$-557.34K	USD	2 Qtrs
NET LOSS BEFORE OTHER EXPENSE	`NETLOSSBEFOREOTHEREXPENSE1`	$-452.95K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`NETLOSSBEFOREOTHEREXPENSE1`	$-155.35K	USD	1 Quarter
NET LOSS BEFORE OTHER EXPENSE	`NETLOSSBEFOREOTHEREXPENSE1`	$-421.93K	USD	2 Qtrs
Interest expense	`InterestExpense`	$-6.06K	USD	2 Qtrs
Interest expense	`InterestExpense`	$-3.15K	USD	1 Quarter
Interest expense	`InterestExpense`	$-10.54K	USD	2 Qtrs
Interest expense	`InterestExpense`	$-5.34K	USD	1 Quarter
Total other expense	`OtherExpenses`	$-6.06K	USD	2 Qtrs
Total other expense	`OtherExpenses`	$-3.15K	USD	1 Quarter
Total other expense	`OtherExpenses`	$-10.54K	USD	2 Qtrs
Total other expense	`OtherExpenses`	$-5.34K	USD	1 Quarter
NET LOSSES	`NETLOSSES1`	$-567.88K	USD	2 Qtrs
NET LOSSES	`NETLOSSES1`	$-458.30K	USD	1 Quarter
NET LOSSES	`NETLOSSES1`	$-427.99K	USD	2 Qtrs
NET LOSSES	`NETLOSSES1`	$-158.50K	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	17.48M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	17.83M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	26.45M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	23.11M	shares	2 Qtrs
NET LOSS PER SHARE	`NETLOSSPERSHARE1`	$-0.02	USD	2 Qtrs
NET LOSS PER SHARE	`NETLOSSPERSHARE1`	$-0.02	USD	2 Qtrs
NET LOSS PER SHARE	`NETLOSSPERSHARE1`	$-0.02	USD	1 Quarter
NET LOSS PER SHARE	`NETLOSSPERSHARE1`	$-0.01	USD	1 Quarter
Net loss for period	`NetLossForPeriod1`	$-158.50K	USD	1 Quarter
Net loss for period	`NetLossForPeriod1`	$-567.88K	USD	2 Qtrs
Net loss for period	`NetLossForPeriod1`	$-427.99K	USD	2 Qtrs
Net loss for period	`NetLossForPeriod1`	$-458.30K	USD	1 Quarter
Currency tranlation gains (losses)	`CurrencyTranlationGainsLosses1`	$-4.66K	USD	1 Quarter
Currency tranlation gains (losses)	`CurrencyTranlationGainsLosses1`	$17.80K	USD	1 Quarter
Currency tranlation gains (losses)	`CurrencyTranlationGainsLosses1`	$3.29K	USD	2 Qtrs
Currency tranlation gains (losses)	`CurrencyTranlationGainsLosses1`	$-17.95K	USD	2 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`TOTALACCUMULATEDOTHERCOMPREHENSIVELOSS1`	$-462.96K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`TOTALACCUMULATEDOTHERCOMPREHENSIVELOSS1`	$-585.83K	USD	2 Qtrs
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`TOTALACCUMULATEDOTHERCOMPREHENSIVELOSS1`	$-140.70K	USD	1 Quarter
TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS	`TOTALACCUMULATEDOTHERCOMPREHENSIVELOSS1`	$-424.69K	USD	2 Qtrs

Cash Flow Statement 31 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-427.99K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-567.88K	USD	2 Qtrs
Amortization expense - license	`AmortizationExpensePerDollarOfGrossRevenue`	$24.17K	USD	Point-in-time
Common stock issued or accrued for services	`CommonStockAdditionalSeriesSharesIssued`	251,050.00	shares	Point-in-time
(Increase) in inventory	`IncreaseDecreaseInInventoryForLongTermContractsOrPrograms`	$-4.12K	USD	2 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$60.85K	USD	2 Qtrs
Increase in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$93.92K	USD	2 Qtrs
Total adjustments	`TotalAdjustments1`	$554.04K	USD	2 Qtrs
Total adjustments	`TotalAdjustments1`	$331.94K	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-96.05K	USD	2 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.84K	USD	2 Qtrs
Proceeds from convertible notes payable, net of repayments	`ProceedsFromConvertibleNotesPayableNetOfRepayments`	$8.00K	USD	2 Qtrs
Short-term loans, net of repayments	`ShortTermLoansNetOfRepayments1`	$-518.00	USD	2 Qtrs
Short-term loans, net of repayments	`ShortTermLoansNetOfRepayments1`	$94.92K	USD	2 Qtrs
Short-term loans - related party, net of repayments	`ShortTermLoansRelatedPartyNetOfRepayments1`	$4.26K	USD	2 Qtrs
Proceeds from the sale of common stock	`ProceedsFromTheSaleOfCommonStock1`	$7.18K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$99.18K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$14.66K	USD	2 Qtrs
Effect of foreign currency	`GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness`	$-807.00	USD	2 Qtrs
Effect of foreign currency	`GainLossOnComponentsExcludedFromAssessmentOfForeignCurrencyCashFlowHedgeEffectiveness`	$672.00	USD	2 Qtrs
NET INCREASE IN CASH AND CASH EQUIVALENTS	`NETINCREASEINCASHANDCASHEQUIVALENTS1`	$15.00	USD	2 Qtrs
NET INCREASE IN CASH AND CASH EQUIVALENTS	`NETINCREASEINCASHANDCASHEQUIVALENTS1`	$3.80K	USD	2 Qtrs
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashEquivalentsAtCarryingValue`	$4.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	`CashEquivalentsAtCarryingValue`	$3.81K	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$4.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$33.00	USD	Point-in-time
CASH AND CASH EQUIVALENTS - END OF PERIOD	`CashEquivalentsAtCarryingValue`	$3.81K	USD	Point-in-time
Cash paid during the period for Interest	`InterestPaid`	$1.50K	USD	2 Qtrs
Conversion of accounts payable to common stock	`ConversionOfAccountsPayableToCommonStock1`	$39.92K	USD	2 Qtrs
Conversion of accounts payable to common stock	`ConversionOfAccountsPayableToCommonStock1`	$30.00K	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.